Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...

辉瑞还面临着专利悬崖的压力，核心产品Eliquis在2024年的销售额预计为73.66亿美元，尽管增长势头良好，但Ibrance将在2025年面临专利到期风险。为了应对这一挑战，辉瑞通过ADC药物及新药研发进行核心产品的生命周期管理，积极布局新增长点 ...

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...

其中，原公司副总经理刘爱华女士，已超过法定退休年龄，退休时与公司签订了返聘合同，现该返聘合同将于近期到期，且到期后不再续签。刘爱华女士不再担任副总经理职务，后续将不再在公司担任任何职务。

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...